Quick Answer
Bionano Genomics, Inc. reported Total Revenue of $28.51 million for fiscal year 2025.
Bionano Genomics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $28.51M | -7.4% |
| 2024 | $30.78M | -14.8% |
| 2023 | $36.12M | +29.9% |
| 2022 | $27.80M | +54.6% |
| 2021 | $17.98M | +111.5% |
| 2020 | $8.50M | -16.1% |
| 2019 | $10.13M | -15.6% |
| 2018 | $12.00M | +26.3% |
| 2017 | $9.51M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.37M | +21.3% | +9.4% |
| June 30, 2025 | $6.73M | -13.4% | +4.3% |
| March 31, 2025 | $6.46M | -26.4% | +6.3% |
| September 30, 2024 | $6.07M | -34.8% | -21.9% |
| June 30, 2024 | $7.77M | -10.3% | -11.4% |
| March 31, 2024 | $8.77M | +18.3% | -5.9% |
| September 30, 2023 | $9.32M | +29.0% | +7.6% |
| June 30, 2023 | $8.66M | +29.9% | +16.8% |
- Bionano Genomics, Inc. showed a decrease of -7.4% in Total Revenue compared to the prior fiscal year.
- Over the 2017–2025 period, Bionano Genomics, Inc.’s total revenue has grown by 199.9% (from $9.51 million to $28.51 million).
- The most recent figure is from Bionano Genomics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: